SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION, 62.5mg elemental iron/5mL, 10 (5mL vials) p...
FDA Drug Recall #D-0172-2017 — Class III — November 17, 2016
Recall Summary
| Recall Number | D-0172-2017 |
| Classification | Class III — Low risk |
| Date Initiated | November 17, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | West-Ward Pharmaceuticals Corp. |
| Location | Eatontown, NJ |
| Product Type | Drugs |
| Quantity | 5,142 Shelf-packs |
Product Description
SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION, 62.5mg elemental iron/5mL, 10 (5mL vials) per shelf pack, Rx only, Mfd: Hikma Farmaceutica (Portugal,) SA Distributed by: Westward Eatowntown NJ 07724 USA, Shelf pack NDC 0143-9570-10, Unit dose NDC 0143-9570-01
Reason for Recall
Subpotent Drug: Product has an an out of specification in iron assay analysis found during 18 month stability testing.
Distribution Pattern
US nationwide
Lot / Code Information
Lot #: 152032.1, Exp. Date. 2/2017
Other Recalls from West-Ward Pharmaceuticals Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0093-2018 | Class III | Dexamethasone Sodium Phosphate Injection, USP, ... | Nov 6, 2017 |
| D-0094-2018 | Class III | Dexamethasone Sodium Phosphate Injection, USP, ... | Nov 6, 2017 |
| D-0147-2017 | Class III | Amoxicillin for Oral suspension, USP 400 mg/5 m... | Nov 4, 2016 |
| D-1045-2017 | Class II | Phenobarbital Tablets, USP 60mg 100=count bottl... | Oct 3, 2016 |
| D-1515-2016 | Class III | Amoxicillin For Oral Suspension, USP - Dye Free... | Aug 18, 2016 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.